ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Interview: A Conversation with Robert Carlson

October 5, 2012

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

DeVita’s Appointment Reportedly On Carter’s Desk, May Be Made Official By End Of Month

May 9, 1980

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998